What is the basis for treatment selection in renal cell carcinoma (RCC)?

Updated: Feb 19, 2021
  • Author: Kush Sachdeva, MD; Chief Editor: E Jason Abel, MD  more...
  • Print

The therapeutic approach to renal cell carcinoma (RCC) is guided by the probability of cure, which is related directly to the stage or degree of tumor dissemination. [2, 3, 4] More than 50% of patients with early-stage renal cell carcinoma are cured, but the outcome for stage IV disease is poor.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!